Clinical Trials Directory

Trials / Conditions / Uterine Leiomyosarcoma

Uterine Leiomyosarcoma

12 registered clinical trials studyying Uterine Leiomyosarcoma — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPh 2 Elacestrant in ER Positive Uterine Sarcomas
NCT07467772
Dana-Farber Cancer InstitutePhase 2
RecruitingPhase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS
NCT07076186
M.D. Anderson Cancer CenterPhase 2
RecruitingLetrozole in Uterine Leiomyosarcoma
NCT05649956
GOG FoundationPhase 2
Active Not RecruitingComparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroid
NCT06244251
West China Second University HospitalN/A
Active Not RecruitingCytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
NCT04727242
Stanford UniversityPhase 2
CompletedCombined CRS With HIPEC in Women With Inadvertently Morcellated uLMS
NCT06678763
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University—
WithdrawnPazopanib for Treating Uterine Leiomyosarcoma
NCT02378142
Gynecologic Oncology GroupPhase 2
CompletedAZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00659360
National Cancer Institute (NCI)Phase 2
CompletedSunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
NCT00378911
National Cancer Institute (NCI)Phase 2
CompletedZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissu
NCT00390234
National Cancer Institute (NCI)Phase 2
CompletedSorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
NCT00245102
National Cancer Institute (NCI)Phase 2
CompletedAdjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
NCT00614835
Memorial Sloan Kettering Cancer CenterN/A